Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  International Journal of Immunopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0192-0561(91)90160-9PMID 1667651
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Marijuana and immunity.

  1992cited by this paper
• Marijuana and immunity: tetrahydrocannabinol mediated inhibition of lymphocyte blastogenesis.

  1990cited by this paper
• In vitro production of IL 1β, IL 1α, TNF and IL 2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation

  1989cited by this paper
• Prevention and reversal of delta-9-tetrahydrocannabinol induced depression of natural killer cell activity by interleukin-2.

  1989cited by this paper
• Interleukin‐2 Augmentation of Interleukin‐1 and Prostaglandin E2 Production

  1989cited by this paper
• In vitro production of IL 1 beta, IL 1 alpha, TNF and IL2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation.

  1989cited by this paper
• The effects of 9-ene-tetrahydrocannabinol on hormone release and immune function.

  1989cited by this paper
• Cocaine or delta 9-tetrahydrocannabinol does not affect cellular cytotoxicity in vitro.

  1989cited by this paper
• Cocaine or Δ9-tetrahydrocannabinol does not affect cellular cytotoxicity in vitro

  1989cited by this paper
• Inhibition of natural killer cell function by marijuana components.

  1988cited by this paper
• Marijuana and immunity.

  1988cited by this paper
• Drugs of abuse and virus susceptibility.

  1988cited by this paper
• Determination and characterization of a cannabinoid receptor in rat brain.

  1988cited by this paper
• Differential effects of interferon-alpha and interferon-gamma on interleukin 1 secretion by monocytes.

  1987cited by this paper
• Differential effects of marijuana components on proliferation of spleen, lymph node and thymus cells in vitro.

  1987cited by this paper
• Immunomodulation by morphine and marijuana.

  1987cited by this paper
• Suppressive effect of delta 9-tetrahydrocannabinol in vitro on phagocytosis by murine macrophages.

  1986cited by this paper
• Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.

  1986cited by this paper
• In vitro and in vivo suppressive effects of delta-9-tetrahydrocannabinol on interferon production by murine spleen cells.

  1986cited by this paper
• Δ9-Tetrahydrocannabinol Decreases Alpha/Beta Interferon Response to Herpes Simplex Virus Type 2 in the B6C3F1 Mouse 1

  1986cited by this paper
• Marijuana effects on immunity: suppression of human natural killer cell activity of delta-9-tetrahydrocannabinol.

  1986cited by this paper
• Cellular effects of cannabinoids.

  1986cited by this paper
• Immune interferon: a pleiotropic lymphokine with multiple effects.

  1985cited by this paper
• Pretreatment of plastic Petri dishes with fetal calf serum. A simple method for macrophage isolation.

  1979cited by this paper
• Phytohemagglutinin-induced lymphocyte transformation in humans receiving delta9-tetrahydrocannabinol.

  1976cited by this paper
• Mitogen-induced blastogenic responses of lymphocytes from marihuana smokers.

  1975cited by this paper

• Recreational cannabis use is the driving factor for participation in medical cannabis trials in inflammatory rheumatic diseases.

  2025cites this paper
• CBD’s potential impact on Parkinson’s disease: An updated overview

  2024cites this paper
• Enhancement of cannabidiol oral bioavailability through the development of nanostructured lipid carriers: In vitro and in vivo evaluation studies

  2024cites this paper
• Cannabidiol as a possible treatment for endometriosis through suppression of inflammation and angiogenesis

  2024cites this paper
• The effects of a brand-specific, hemp-derived cannabidiol product on physiological, biochemical, and psychometric outcomes in healthy adults: a double-blind, randomized clinical trial

  2024cites this paper
• Cannabidiol Mediates In Vitro Attenuation of Proinflammatory Cytokine Responses in Psoriatic Disease

  2024cites this paper
• Effect of Cannabidiol on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells

  2023cites this paper
• The role of cannabidiol in aging.

  2023cites this paper
• A novel mechanism of cannabidiol in suppressing ovarian cancer through LAIR‐1 mediated mitochondrial dysfunction and apoptosis

  2023cites this paper
• The effects of cannabidiol on immune function and health parameters in senior horses.

  2023cites this paper
• Pharmacognosy and Effects of Cannabinoids in the Vascular System.

  2022cites this paper
• In vitro exposure of whole blood to a cannabinoid mixture impairs the quality of red blood cells and platelets.

  2022cites this paper
• Impact of Δ9-Tetrahydrocannabinol on Rheumatoid Arthritis Synovial Fibroblasts Alone and in Co-Culture with Peripheral Blood Mononuclear Cells

  2022cites this paper
• Inclusion of Medium-Chain Triglyceride in Lipid-Based Formulation of Cannabidiol Facilitates Micellar Solubilization In Vitro, but In Vivo Performance Remains Superior with Pure Sesame Oil Vehicle

  2021cites this paper
• Effects of Cannabidiol on the In Vitro Lymphocyte Pro-Inflammatory Cytokine Production of Senior Horses.

  2021cites this paper
• Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression

  2021cites this paper
• Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?

  2021cites this paper
• Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?

  2021cites this paper
• The Potential Use of Cannabis in Tissue Fibrosis

  2021cites this paper
• Cannabis and Autoimmunity: Possible Mechanisms of Action

  2021cites this paper
• In vivo and in vitro anti-inflammatory activity evaluation of Lebanese Cannabis sativa L. ssp. indica (Lam.).

  2020cites this paper
• Biological effects of Cannabidiol on normal human healthy cell populations: Systematic review of the literature.

  2020cites this paper
• Investigation of the effects of cannabidiol on vacuous chewing movements, locomotion, oxidative stress and blood glucose in rats treated with oral haloperidol

  2020cites this paper
• Immune Responses Regulated by Cannabidiol

  2020cites this paper
• Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease

  2020cites this paper
• Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson’s Disease and l-DOPA-Induced Dyskinesia

  2019cites this paper
• Cannabis Sativa Revisited—Crosstalk between microRNA Expression, Inflammation, Oxidative Stress, and Endocannabinoid Response System in Critically Ill Patients with Sepsis

  2019cites this paper
• Cannabidiol—from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer

  2019cites this paper
• Medical Cannabis in Treatment of Resistant Familial Mediterranean Fever

  2019cites this paper
• Evaluation of the effect of cholesterol supplementation on experimental pulmonary arterial hypertension

  2018cites this paper
• Cannabidiol restores differentiation capacity of LPS exposed adipose tissue mesenchymal stromal cells

  2018cites this paper
• A Cross-Sectional Study of Cannabidiol Users

  2018cites this paper
• Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis

  2018cites this paper
• Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer

  2018cites this paper
• Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation

  2017cites this paper
• Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review

  2017cites this paper
• Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation

  2016cites this paper
• Cardiac cachexia: hic et nunc

  2016cites this paper
• Circulating Interferon-Gamma Levels Are Associated with Low Body Weight in Newly Diagnosed Kenyan Non-Substance Using Tuberculosis Individuals

  2016cites this paper
• Cardiac cachexia: hic et nunc: "hic et nunc" - here and now.

  2015cites this paper
• Δ9-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles

  2015cites this paper
• Short report Open Access

  2015cites this paper
• Δ9-Tetrahydrocannabinol Treatment During Human Monocyte Differentiation Reduces Macrophage Susceptibility to HIV-1 Infection

  2014cites this paper
• Recent insights on the molecular mechanisms and therapeutic approaches for cardiac cachexia.

  2014cites this paper
• Non-psychotropic analgesic drugs from the endocannabinoid system: "magic bullet" or "multiple-target" strategies?

  2013cites this paper
• Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview

  2013cites this paper
• Neuroprotective agents: cannabinoids.

  2012cites this paper
• The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism

  2010cites this paper
• Delta9-tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro.

  2009cites this paper
• NUTRACÈUTICS: IMPLICACIÓ TERAPÈUTICA EN CAQUÈXIA CANCEROSA I DIABETIS

  2009cites this paper
• Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells*

  2009cites this paper
• Cannabidiol: A Promising Drug for Neurodegenerative Disorders?

  2009cites this paper
• Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.

  2008cites this paper
• The Cannabinoid Delta-9-tetrahydrocannabinol Mediates Inhibition of Macrophage Chemotaxis to RANTES/CCL5: Linkage to the CB2 Receptor

  2008cites this paper
• Novel approaches to the treatment of cachexia.

  2008cites this paper
• Targets in clinical oncology: the metabolic environment of the patient.

  2007cites this paper
• Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor‐independent myeloperoxidase‐inhibiting mechanism

  2007cites this paper
• Emerging drugs for cancer cachexia

  2007cites this paper
• Suppressive effects of cannabidiol on antigen-specific antibody production and functional activity of splenocytes in ovalbumin-sensitized BALB/c mice.

  2007cites this paper
• Physiological doses of cannabinoids do not adversely affect MCL viability

  2007cites this paper
• Cannabinoid Modulation of Chemotaxis of Macrophages and Macrophage-like Cells

  2007cites this paper
• Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL‐2H3 mast cells

  2007cites this paper
• Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance.

  2007cites this paper
• Cannabidiol – Recent Advances

  2007cites this paper
• Correspondence Duty of care

  2007cites this paper
• Estimation of the hypothermic component in neuroprotection provided by cannabinoids following cerebral ischemia.

  2006cites this paper
• New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity.

  2006cites this paper
• Cannabinoids, immune system and cytokine network.

  2006cites this paper
• Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?

  2005influential citation
• Effects on the immune system.

  2005cites this paper
• Cannabinoid influence on cytokine profile in multiple sclerosis

  2005cites this paper
• The use of cannabinoids in multiple sclerosis

  2005cites this paper
• Cannabidiol as a potential medicine

  2005cites this paper
• Cachexia Associated with AIDS

  2005cites this paper
• MECANISMES ASSOCIATS AL DESENVOLUPAMENT DE LA CAQUÈXIA EN ESTATS PATOLÒGICS: IMPLICACIONS TERAPÈUTIQUES

  2005cites this paper
• The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations.

  2005cites this paper
• 2‐Arachidonoyl‐glycerol suppresses interferon‐γ production in phorbol ester/ionomycin‐activated mouse splenocytes independent of CB1 or CB2

  2005cites this paper
• The pharmacological treatment of cachexia.

  2004cites this paper
• Marijuana and Madness: The cannabinoid system: from the point of view of a chemist

  2004cites this paper
• Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw

  2004cites this paper
• A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis.

  2004cites this paper
• Cannabinoids in Models of Chronic Inflammatory Conditions

  2004cites this paper
• Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.

  2003cites this paper
• Cannabidiol: An Overview of Some Pharmacological Aspects

  2002cites this paper
• Cancer cachexia: A therapeutic approach

  2001cites this paper
• The cannabinoids: an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection.

  2001cites this paper
• The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.

  2000cites this paper
• Immunoactive cannabinoids: therapeutic prospects for marijuana constituents.

  2000cites this paper
• Marijuana and Medicine

  1999cites this paper
• Marihuana and the Immune System

  1999cites this paper
• Effects of Cannabinoids on the Immune System and Central Nervous System

  1999cites this paper
• Cannabinoid inhibition of the processing of intact lysozyme by macrophages: evidence for CB2 receptor participation.

  1999cites this paper
• Marijuana, immunity and infection.

  1998cites this paper
• Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation.

  1998cites this paper
• Marijuana, stress and suicide: a neuroimmunological explanation.

  1998cites this paper
• Delta9-tetrahydrocannabinol suppresses macrophage costimulation by decreasing heat-stable antigen expression.

  1998cites this paper
• Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease.

  1998cites this paper
• Duty of care.

  1998cites this paper
• Expression of the CB1 cannabinoid receptor in macrophage-like cells from brain tissue: immunochemical characterization by fusion protein antibodies.

  1998cites this paper
• Molecular aspects of cannabinoid receptors.

  1997cites this paper